Merit Medical Systems INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
NASDAQ
Merit Medical Systems, Inc. reported robust financial results for the fiscal year ended December 31, 2025, with significant revenue growth and increased profitability driven by strategic acquisitions and strong demand.
NASDAQ
Merit Medical Systems has filed an amendment to its annual report to correct the five-year cumulative total return information for NASDAQ Stocks within its original filing.
NASDAQ
Merit Medical Systems, Inc. announces a successful fiscal year 2024, marked by significant revenue growth, strategic acquisitions, and advancements in key product areas.
NASDAQ
10-K: Merit Medical Reports Record Revenue in 2023, Driven by Strong US Demand and International Growth
Merit Medical Systems, Inc., a leading manufacturer of medical devices, announced record sales of $1.257 billion for the year ended December 31, 2023, marking a 9.2% increase from 2022, fueled by robust demand in the U.S. and favorable international sales trends.